Valued at $15.0M at its early-stage round, Mar 2022. Nothing has traded since.
- ·Watch Revel Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Revel Pharmaceuticals funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2022 | Early Stage VC | $5.8M | ▮ | ▮ |
| Mar 2021 | Seed Round | $800K | ▮ | ▮ |
| Dec 2019 | Seed Round | $533K | ▮ | ▮ |
Membership and data by Private Market View
Revel Pharmaceuticals valuation
Revel Pharmaceuticals was valued at $15 million at its early-stage round in Mar 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Revel Pharmaceuticals raised?
Revel Pharmaceuticals has raised $14.7 million in total; 3 of its rounds are on record, from 2019 on. The largest on record was an $800,000 seed round in Mar 2021; the most recent was a $5.8 million early-stage round in Feb 2022.
Revel Pharmaceuticals has filed 3 Form Ds with the SEC since 2020, most recently in Mar 2022 ($5.8 million sold to 3 investors).
How Revel Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Revel Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Revel Pharmaceuticals
- What is Revel Pharmaceuticals worth?
- Revel Pharmaceuticals is valued at $15.0M as of Oct 2026. Valued at $15.0M at its early-stage round, Mar 2022. Nothing has traded since.
- How much has Revel Pharmaceuticals raised?
- Revel Pharmaceuticals has raised $14.7M in total funding across 3 recorded rounds.
- When did Revel Pharmaceuticals last raise?
- Revel Pharmaceuticals last raised in Feb 2022 (Early Stage VC), raising $5.8M.